SI0868910T1 - Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms - Google Patents

Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms

Info

Publication number
SI0868910T1
SI0868910T1 SI9830339T SI9830339T SI0868910T1 SI 0868910 T1 SI0868910 T1 SI 0868910T1 SI 9830339 T SI9830339 T SI 9830339T SI 9830339 T SI9830339 T SI 9830339T SI 0868910 T1 SI0868910 T1 SI 0868910T1
Authority
SI
Slovenia
Prior art keywords
polymer
binders
preparation
powders
solid pharmaceutical
Prior art date
Application number
SI9830339T
Other languages
English (en)
Slovenian (sl)
Inventor
Karl Dr. Kolter
Kristin Dr. Tiefensee
Katrin Dr. Zeitz
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of SI0868910T1 publication Critical patent/SI0868910T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9830339T 1997-03-10 1998-03-02 Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms SI0868910T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19709663A DE19709663A1 (de) 1997-03-10 1997-03-10 Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
EP98103626A EP0868910B1 (de) 1997-03-10 1998-03-02 Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen

Publications (1)

Publication Number Publication Date
SI0868910T1 true SI0868910T1 (en) 2003-04-30

Family

ID=7822750

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830339T SI0868910T1 (en) 1997-03-10 1998-03-02 Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms

Country Status (8)

Country Link
US (1) US6066334A (xx)
EP (1) EP0868910B1 (xx)
JP (1) JPH10298111A (xx)
AT (1) ATE230259T1 (xx)
DE (2) DE19709663A1 (xx)
DK (1) DK0868910T3 (xx)
ES (1) ES2189997T3 (xx)
SI (1) SI0868910T1 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
ATE329579T1 (de) * 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
US7094831B2 (en) * 2000-09-29 2006-08-22 Basf Aktiengellsellschaft Aqueous polymer dispersion
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP4575654B2 (ja) * 2003-09-05 2010-11-04 エスエス製薬株式会社 溶解性と流動性を改善した医薬組成物
US8168219B2 (en) * 2005-11-30 2012-05-01 Isp Investments Inc. Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
JP5209492B2 (ja) * 2005-12-21 2013-06-12 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
FR2898056B1 (fr) * 2006-03-01 2012-01-20 Ethypharm Sa Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
CA2645855C (en) 2006-03-16 2015-02-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
WO2008046799A2 (en) * 2006-10-20 2008-04-24 Basf Aktiengesellschaft Preparation of granules of hydrophilic vitamins
KR20160083132A (ko) * 2007-06-06 2016-07-11 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
WO2008148734A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
CN102083410B (zh) * 2007-06-06 2013-04-17 巴斯夫欧洲公司 用于制备迅速崩解的片剂的药物制剂
TWI583405B (zh) * 2008-02-28 2017-05-21 艾伯維有限公司 錠劑及其製備
US20110178183A1 (en) * 2008-09-25 2011-07-21 Meyer-Boehm Kathrin Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
DE102011121589A1 (de) * 2011-12-20 2013-06-20 Johns Manville Europe Gmbh Binderverfestigtes, textiles Flächengebilde, Verfahren zu dessen Herstellung und dessen Verwendung
ES2717469T3 (es) 2012-08-15 2019-06-21 Tris Pharma Inc Comprimido masticable de metilfenidato de liberación prolongada
CN104644557B (zh) * 2013-11-22 2017-10-31 上海宣泰医药科技有限公司 卟啉铁固体分散体及其制备方法
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
KR20190082847A (ko) * 2016-11-07 2019-07-10 메르크 파텐트 게엠베하 폴리비닐 알코올을 기반으로 하는 반-알코올-유도 용량 급방출 정제
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
DE3810343A1 (de) * 1988-03-26 1989-10-05 Basf Ag Verfahren zur herstellung von festen pharmazeutischen retardformen
US5252704A (en) * 1992-06-05 1993-10-12 Air Products And Chemicals, Inc. Redispersible polymer powders using polyvinyl pyrrolidone as a dispersing aid
DE4220782A1 (de) * 1992-06-25 1994-01-05 Basf Ag Verfahren zur Herstellung von festen pharmazeutischen Retardformen
US5705553A (en) * 1993-05-29 1998-01-06 Hoechst Aktiengesellschaft Copolymers containing carboxyl groups in aqueous dispersion form or redispersible powder form and their water-soluble salts, processes for their preparation and their use as thickeners in aqueous formulations
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
FR2727976A1 (fr) * 1994-12-09 1996-06-14 Rhone Poulenc Chimie Poudres redispersables dans l'eau de polymeres filmogenes prepares a partir de monomeres a insaturation ethylenique
DE19711712A1 (de) * 1997-03-20 1998-09-24 Wacker Chemie Gmbh Verfahren zur Herstellung von blockstabilen, in Wasser redispergierbaren Polymerpulvern

Also Published As

Publication number Publication date
US6066334A (en) 2000-05-23
EP0868910B1 (de) 2003-01-02
DK0868910T3 (da) 2003-02-24
EP0868910A3 (de) 1999-09-15
DE19709663A1 (de) 1998-09-17
ES2189997T3 (es) 2003-07-16
JPH10298111A (ja) 1998-11-10
DE59806776D1 (de) 2003-02-06
ATE230259T1 (de) 2003-01-15
EP0868910A2 (de) 1998-10-07

Similar Documents

Publication Publication Date Title
SI0868910T1 (en) Use of redispersible polymer powders or polymer granulates as binders for the preparation of solid pharmaceutical delivery forms
SI0868912T1 (en) Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
AUPQ573300A0 (en) Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
NZ502869A (en) Solid pharmaceutical dosage forms of glitazone in a particulate dispersion
GB2186485B (en) Slow release formulation
HRP20010463B1 (en) Controlled release galantamine composition
WO2001047498A3 (en) Hydrogel-driven layered drug dosage form comprising sertraline
HU901380D0 (en) Controlling released coat for long-acting compositions
IL102591A (en) Compositions for the sustained and controlled release of peptide medicaments and their preparation
CA2354034A1 (en) Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
WO2002080976A3 (en) Hsa-free formulations of interferon-beta
ATE261300T1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
DE69813872D1 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
IL135316A (en) Oxiranyl-triazoline thiones, their preparation and microbicidal compositions comprising them
EP1087009A3 (en) Pellet compositions
BG105303A (en) Pharmaceutical compositions comprising ibuprofen and domperidone
HUP0102460A3 (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use
AU1556000A (en) Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
WO2001066668A3 (en) Soil additive in the form of a coating
AU2001278804A1 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
HUP0104244A3 (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
HU9700244D0 (en) 3-[1-phenyl-3-(4'-halogenide-biphenyl-4-yl)-3-3-oxo-or hydroxipropile]-4-acyloxi-cumarine derivatives and rodenticide compositions containing these compounds as active ingredients, and preparation thereof
SG25394G (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein.